Mission and Aims

COGNO's mission is:

“The achievement of better health outcomes for patients and those affected by brain tumours through clinical trials research”.

The Group’s aims include:

1. To promote the use of clinical trials in evaluating current therapies, new treatments and supportive interventions for brain tumours and to improve the impact of new clinical trials on future clinical practice.
2. To engage members of the medical/scientific community through participation to assist in the conduct, evaluation, promotion and development of clinical trials in brain tumours.
3. To promote the incorporation of translational studies into new clinical trials in brain tumours.
4. To freely publish the results of research and clinical trials and to make available for general use, on the same terms to all interested bodies, licences for Australian and New Zealand patents issued in the course of research and clinical trials.